Press Release: Harnessing Digital Twins for Pharmaceutical Innovation
In a keynote at the Technology Networks’ Laboratory of the Future 2025 event, Shoeb Javed, Chief Product Officer at iGrafx, highlighted the transformative potential of Digital Twins of Organizations (DTOs) in the pharmaceutical sector. A DTO serves as a dynamic digital replica of a company’s operational processes, enabling firms to identify inefficiencies, assess risks, and continually enhance their workflows with the aid of artificial intelligence (AI).
Unlike traditional 3D models, DTOs represent an evolving complex of end-to-end processes—from drug discovery to regulatory submissions. Utilizing data from enterprise systems and historical performance, DTOs deliver real-time insights, providing a holistic view of how a company operates. Javed emphasized that the DTO allows for objective visibility into business processes, enabling smarter design and optimization strategies.
AI enhances DTO capabilities, evolving them from passive dashboards into proactive decision-making tools. Advanced machine learning models can predict workflow outcomes, identify compliance risks, and suggest corrective measures. For instance, the DTO can flag potential regulatory failures early in the process, vastly improving operational efficiency.
Javed illustrated DTO benefits through a case study of a global pharma company that faced concurrent supply chain delays and a product launch. By employing iGrafx’s AI-driven solutions, the firm successfully streamlined 40 workflows, averting substantial financial losses.
For organizations aspiring to adopt DTOs, Javed recommended starting with a centralized repository of existing processes and augmenting it with process mining to truly reflect how work is accomplished. According to Javed, DTOs are not just tools; they represent a framework for transforming industry challenges into opportunities for growth.
————————————————————————
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
————————————————————————
